250 related articles for article (PubMed ID: 31090863)
1. Systematic review of prophylaxis for venous thromboembolism after knee arthroplasty: enoxaparin versus rivaroxaban.
Rodarte RRP; Guimarães JAM; Franco JS; Fonseca L; Nascimento V; Aramburu JPG; Barretto JM
Rev Col Bras Cir; 2019 May; 46(2):e2075. PubMed ID: 31090863
[TBL] [Abstract][Full Text] [Related]
2. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.
Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM
Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185
[TBL] [Abstract][Full Text] [Related]
3. Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total knee arthroplasty: A meta-analysis.
Huang HF; Li SS; Yang XT; Xie Q; Tian XB
Medicine (Baltimore); 2018 Nov; 97(48):e13465. PubMed ID: 30508972
[TBL] [Abstract][Full Text] [Related]
4. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
5. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
6. Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review.
Rashki Kemmak A; Abutorabi A; Alipour V
Clin Drug Investig; 2020 Aug; 40(8):715-725. PubMed ID: 32578155
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.
Charters MA; Frisch NB; Wessell NM; Dobson C; Les CM; Silverton CD
J Arthroplasty; 2015 Jul; 30(7):1277-80. PubMed ID: 25724111
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study.
Xie J; Ma J; Huang Q; Yue C; Pei F
Med Sci Monit; 2017 Feb; 23():704-711. PubMed ID: 28174415
[TBL] [Abstract][Full Text] [Related]
10. Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis.
Feng W; Wang X; Huang D; Lu A
Pharmacol Res; 2021 Apr; 166():105438. PubMed ID: 33540046
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Duggan ST
Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
[TBL] [Abstract][Full Text] [Related]
12. Does the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery?
Kerr DL; Butler S; Read AC; Harris IA
ANZ J Surg; 2019 Oct; 89(10):1211-1216. PubMed ID: 31234237
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
Cao YB; Zhang JD; Shen H; Jiang YY
Eur J Clin Pharmacol; 2010 Nov; 66(11):1099-108. PubMed ID: 20812009
[TBL] [Abstract][Full Text] [Related]
14. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Squizzato A; Lussana F; Cattaneo M
Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Huisman MV; Quinlan DJ; Dahl OE; Schulman S
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):652-60. PubMed ID: 20923996
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of rivaroxaban versus enoxaparin in the prevention of venous thromboembolism after hip or knee replacement.
Turun S; Banghua L; Yuan Y; Zhenhui L; Ying N; Jin C
Thromb Res; 2011 Jun; 127(6):525-34. PubMed ID: 21397931
[TBL] [Abstract][Full Text] [Related]
17. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin.
Yen SH; Lin PC; Kuo FC; Wang JW
Biomed J; 2014; 37(4):199-204. PubMed ID: 25116715
[TBL] [Abstract][Full Text] [Related]
18. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Lassen MR; Ageno W; Borris LC; Lieberman JR; Rosencher N; Bandel TJ; Misselwitz F; Turpie AG;
N Engl J Med; 2008 Jun; 358(26):2776-86. PubMed ID: 18579812
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty.
Hur M; Park SK; Koo CH; Jung ED; Kang P; Kim WH; Kim JT; Jung CW; Bahk JH
Acta Orthop; 2017 Dec; 88(6):634-641. PubMed ID: 28787226
[TBL] [Abstract][Full Text] [Related]
20. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Eriksson BI; Rosencher N; Friedman RJ; Homering M; Dahl OE
Thromb Res; 2012 Aug; 130(2):147-51. PubMed ID: 22225858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
